Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Regenerative Medicine Market

Veterinary Regenerative Medicine Market Trends

Report ID: GMI9919
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Veterinary Regenerative Medicine Market Trends

Innovations in stem cell research, tissue engineering, and biologics are significantly enhancing the capabilities and applications of regenerative medicine, leading to more effective and targeted treatments, thereby expanding the market growth in coming years.

For instance, traditionally, the induction of induced pluripotent stem cells (iPSCs) required feeder cells from different species, introducing certain risks to the animals during stem cell therapy. Addressing this challenge, a team of scientists from Osaka Metropolitan University developed an innovative method to reprogram stem cells from canine urine. This non-invasive and pain-free technique marked a significant step forward in veterinary regenerative treatments. This advancement opens new doors for therapies in regenerative medicine and genetic disease research in veterinary science, paving the way for more personalized and effective treatments.
Thus, such innovations are driving significant opportunities in the market.
Moreover, the growing animal healthcare expenditure, enhanced diagnostic technologies, growing government support, and strategic expansions by major players further propel the market demand.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary regenerative medicine industry was valued at USD 265.5 million in 2023 and is anticipated to register 9.9% CAGR between 2024 and 2032, driven by rising incidence of chronic and degenerative conditions and the growing advancement in regenerative medicine

The orthopedic segment in the market is expected to reach USD 278.1 million by 2032 due to its high demand for treatments addressing musculoskeletal issues prevalent in companion and livestock animals.

Asia Pacific veterinary regenerative medicine market is expected to witness USD 10.4% CAGR through 2032 due to increasing pet ownership, rising awareness about advanced veterinary treatments, and growing animal healthcare expenditure.

Animal Cell Therapies, Inc., Ardent, Bioceltix, Boehringer Ingelheim International GmbH, CTSL (Cell Therapy Sciences), Dechra, Enso Discoveries, Magellan Stem Cells, Medrego and Regeneus Ltd (Cambium Bio Ltd.), among others.